Skip to contentB
Bio-Path Holdings, Inc.
B
BPTHBio-Path Holdings, Inc. Q3 2020 · 10-Q
Revenue—
Net Income-$2.97M-$2.97MN/M vs Q3 2019 EPS Diluted-$0.80-$0.80N/M vs Q3 2019 Operating Income-$2,970,000N/M Operating Cash Flowderived-$2,353,000N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Path Holdings, Inc. · CIK 1133818 · Engraved from SEC EDGAR
ended Sep 30, 2020 · filed Nov 12, 2020 · 43 d after period end